News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
877,441 Results
Type
Article (88434)
Company Profile (813)
Press Release (788164)
Multimedia
Podcasts (221)
Webinars (34)
Section
Business (233442)
Career Advice (4155)
Deals (39928)
Drug Delivery (168)
Drug Development (91562)
Employer Resources (207)
FDA (18488)
Job Trends (17461)
News (398375)
Policy (40007)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (4)
Academia (3042)
Academic (2)
Accelerated approval (46)
Adcomms (37)
Allergies (178)
Alliances (56985)
ALS (209)
Alzheimer's disease (1900)
Antibody-drug conjugate (ADC) (443)
Approvals (18741)
Artificial intelligence (758)
Autoimmune disease (263)
Automation (56)
Bankruptcy (407)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (225)
Biotechnology (486)
Bladder cancer (189)
Brain cancer (76)
Breast cancer (740)
Cancer (5805)
Cardiovascular disease (514)
Career advice (3585)
Career pathing (48)
CAR-T (337)
CDC (72)
Celiac Disease (2)
Cell therapy (931)
Cervical cancer (45)
Clinical research (78010)
Collaboration (2164)
Company closure (7)
Compensation (1345)
Complete response letters (96)
COVID-19 (3019)
CRISPR (112)
C-suite (1107)
Cystic fibrosis (161)
Data (7416)
Decentralized trials (3)
Denatured (82)
Depression (179)
Dermatology (71)
Diabetes (600)
Diagnostics (7440)
Digital health (59)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (379)
Drug pricing (239)
Drug shortages (39)
Duchenne muscular dystrophy (288)
Earnings (101395)
Editorial (72)
Employer branding (25)
Employer resources (174)
Events (136726)
Executive appointments (1129)
FDA (22159)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (33)
Funding (1781)
Gene editing (242)
Generative AI (85)
Gene therapy (764)
GLP-1 (1219)
Government (5518)
Grass and pollen (8)
Guidances (404)
Healthcare (21056)
HIV (84)
Huntington's disease (58)
IgA nephropathy (98)
Immunology and inflammation (333)
Immuno-oncology (97)
Indications (164)
Infectious disease (3380)
Inflammatory bowel disease (224)
Inflation Reduction Act (17)
Influenza (143)
Intellectual property (288)
Interviews (817)
IPO (17978)
IRA (61)
Job creations (5205)
Job search strategy (2870)
JPM (73)
Kidney cancer (20)
Labor market (107)
Layoffs (672)
Leadership (46)
Legal (10169)
Liver cancer (106)
Longevity (31)
Lung cancer (772)
Lymphoma (422)
Machine learning (57)
Management (66)
Manufacturing (1058)
MASH (196)
Medical device (15173)
Medtech (15261)
Mergers & acquisitions (23147)
Metabolic disorders (1618)
mRNA (222)
Multiple sclerosis (186)
NASH (24)
Neurodegenerative disease (442)
Neuropsychiatric disorders (117)
Neuroscience (3462)
Neurotech (2)
NextGen: Class of 2026 (7713)
Non-profit (5131)
Now hiring (75)
Obesity (791)
Opinion (360)
Ovarian cancer (202)
Pain (257)
Pancreatic cancer (279)
Parkinson's disease (375)
Partnered (39)
Patents (596)
Patient recruitment (647)
Peanut (65)
People (67529)
Pharmaceutical (138)
Pharmacy benefit managers (36)
Phase 1 (24095)
Phase 2 (33868)
Phase 3 (25485)
Pipeline (7651)
Policy (377)
Postmarket research (3556)
Preclinical (10816)
Press Release (72)
Prostate cancer (295)
Psychedelics (61)
Radiopharmaceuticals (340)
Rare diseases (1131)
Real estate (7449)
Recruiting (81)
Regulatory (29782)
Reports (75)
Research institute (2759)
Resumes & cover letters (653)
Rett syndrome (34)
RNA editing (24)
RSV (97)
Schizophrenia (182)
Series A (297)
Series B (219)
Service/supplier (30)
Sickle cell disease (115)
Special edition (30)
Spinal muscular atrophy (186)
Sponsored (52)
Startups (4351)
State (2)
Stomach cancer (21)
Supply chain (139)
Tariffs (104)
The Weekly (136)
Vaccines (1241)
Venture capital (112)
Weight loss (543)
Women's health (120)
Worklife (24)
Date
Today (152)
Last 7 days (628)
Last 30 days (2818)
Last 365 days (32940)
2026 (9771)
2025 (33227)
2024 (38126)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39672)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1293)
Alabama (100)
Alaska (7)
Arizona (373)
Arkansas (16)
Asia (51937)
Australia (9129)
California (12994)
Canada (3691)
China (1367)
Colorado (562)
Connecticut (573)
Delaware (395)
Europe (119597)
Florida (1943)
Georgia (425)
Hawaii (4)
Idaho (69)
Illinois (1115)
India (93)
Indiana (612)
Iowa (24)
Japan (524)
Kansas (138)
Kentucky (52)
Louisiana (44)
Maine (87)
Maryland (1600)
Massachusetts (9517)
Michigan (394)
Minnesota (737)
Mississippi (7)
Missouri (158)
Montana (37)
Nebraska (30)
Nevada (144)
New Hampshire (91)
New Jersey (3496)
New Mexico (33)
New York (3444)
North Carolina (1773)
North Dakota (10)
Northern California (6349)
Ohio (404)
Oklahoma (26)
Oregon (55)
Pennsylvania (2600)
Puerto Rico (29)
Rhode Island (53)
South America (1668)
South Carolina (84)
South Dakota (2)
Southern California (5068)
Tennessee (208)
Texas (2101)
United States (46803)
Utah (392)
Vermont (1)
Virginia (331)
Washington D.C. (88)
Washington State (1077)
West Virginia (4)
Wisconsin (146)
Wyoming (2)
There are 877,441 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Gene therapy
MeiraGTx, spying hope in a failed trial, buys back eye disease gene therapy from J&J
J&J will hand over the rights to bota-vec for $25 million upfront, clearing MeiraGTx to seek regulatory approvals in the U.S. and EU in 2027.
April 16, 2026
·
2 min read
·
Annalee Armstrong
Press Releases
What’s Driving the Stem Cell Therapy Market to USD 59.70 Bn? AI, iPSC & Chronic Disease Demand
April 16, 2026
·
23 min read
Press Releases
Mount Sinai Health System and SOPHiA GENETICS Announce Collaboration to Advance Precision Cancer Care from AACR 2026
April 16, 2026
·
5 min read
Press Releases
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services Collaborate to Support ADC Development and Manufacturing
April 16, 2026
·
5 min read
Press Releases
Panome Bio and Audubon Bioscience Partner to Deliver End-to-End FFPE Biospecimen and Metabolomics Solutions for Cancer Researchers
April 16, 2026
·
4 min read
diabetes
Lilly’s Foundayo posts ‘outstanding’ diabetes data, possibly easing FDA safety concerns
Right after the FDA flagged safety concerns for Eli Lilly’s newly approved obesity pill, the pharma posted diabetes data demonstrating a clean safety profile and revealed plans to seek approval in the indication.
April 16, 2026
·
2 min read
·
Gabrielle Masson
Press Releases
Brenig Therapeutics to Present Phase 1 Data for BT-267 at the American Academy of Neurology (AAN) 2026 Annual Meeting
April 16, 2026
·
3 min read
Insights
Can Europe turn world-class science into world-class scale?
Despite exceptional regional hubs and research strength, investors say Europe still needs more integrated incubators, smarter regulation and broader pools of patient capital to keep breakthrough companies growing at home.
April 16, 2026
·
5 min read
·
Jennifer C. Smith-Parker
Press Releases
Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity
April 16, 2026
·
5 min read
Press Releases
Acurx Pharmaceuticals, Inc. Announces up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
April 16, 2026
·
6 min read
1 of 87,745
Next
